Le Lézard
Classified in: Transportation, Science and technology, Business
Subject: DIV

Aptiv Declares Quarterly Dividend


DUBLIN, Jan. 23, 2020 /PRNewswire/ -- Aptiv PLC (NYSE: APTV), a global technology company enabling the future of mobility, today announced that its Board of Directors declared a quarterly cash dividend of $0.22 per ordinary share, payable on February 19, 2020, to shareholders of record at the close of business on February 5, 2020.

(PRNewsfoto/Aptiv PLC)

About Aptiv
Aptiv is a global technology company that develops safer, greener and more connected solutions enabling the future of mobility. Visit aptiv.com.

SOURCE Aptiv PLC


These press releases may also interest you

at 02:11
Xiao-I Corporation to Announce Full Year 2023 Results
Xiao-I Corporation ("Xiao-I" or "the Company"), a leading artificial intelligence company, announced today that that the Company's full year 2023 financial results will be released before the U.S. market opens on Tuesday April 30, 2024. The Company...

at 02:00
Flash News: OKX to Expand Spot Trading Options with the Addition of Meson Network's MSN Token
OKX, a leading crypto exchange and Web3 technology company, has issued updates for April 26, 2024. OKX to Expand Spot Trading Options...

at 02:00
ELFBAR and LOST MARY unveil progress in combatting illicit vapes
World-leading vaping brands ELFBAR and LOST MARY announced the latest outcomes from their continued global action against...

at 02:00
Amwins Global Risks announces classic car auction
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 02:00
Gogoro and Nebula Energy Launch Battery Swapping Ecosystem and Gogoro CrossOver Smartscooter in Nepal
Nebula Energy and Gogoro Inc , a global technology leader in battery-swapping ecosystems that enable sustainable mobility solutions for cities,...

at 01:35
Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...

More news about Science and technology...


News published on and distributed by: